Immunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.
UV LED decontamination using Phoseon’s KeyPro™ KP100 instrument benefits labs that require high fidelity RNA library prep, sequencing and PCR, or for vaccine development labs that need to quickly and reliably inactivate viruses.
Provides sensitive and specific quantitation of antibodies against four SARS-CoV-2 proteins: nucleocapsid, receptor binding domain, spike 1, and spike 2 viral proteins.
InteliQ Homocysteine Control is a ready-to-use quality control in a barcoded tube designed to monitor the precision of homocysteine test procedures.
InteliQ Immunoassay Plus Control is a ready-to-use quality control in a barcoded tube designed to monitor the precision of immunoassay and therapeutic drug monitoring tests.
InteliQ Immunology Control is a ready-to-use quality control in a barcoded tube designed to monitor the precision of immunology assays.
InteliQ Specialty Immunoassay Control is a ready-to-use quality control in a barcoded tube designed to monitor the precision of specialty immunoassay testing. This control includes additional complex analytes and is designed to complement Bio-Rad's Immunoassay Plus controls.
InteliQ Tumor Marker Control is a ready-to-use quality control in a barcoded tube designed to monitor the precision of immunoassay based oncology testing.
An unassayed, reactive quality control for the qualitative determination of total IgG/IgM and IgG antibodies to SARS-CoV-2.
An unassayed, non-reactive quality control for the qualitative determination of total IgG/IgM and IgG antibodies to SARS-CoV-2.
A trilevel, liquid, comprehensive serum protein control with assayed values for a wide range of methods; includes Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Rheumatoid Factor (RF).
BioReady Gold Nanospheres - Bare (Citrate) - 40 nm, 20 OD in aqueous 0.02 mM sodium citrate
BioReady Gold Nanospheres - Bare (Citrate) - 80 nm, 20 OD in aqueous 0.02 mM sodium citrate
BioReady Gold Nanospheres - Streptavidin - 40 nm, 10 OD in aqueous conjugation buffer
BioReady Gold Nanoshells - Streptavidin - 150 nm, 10 OD in aqueous conjugation buffer
Closed, scalable electroporation system for GMP-compliant cell therapy manufacturing
Closed, scalable electroporation system for GMP-compliant cell therapy manufacturing
The LIAISON® SARS-CoV-2 TrimericS IgG assay enables the reliable detection of Trimeric S spike protein IgG antibodies – the body’s natural defense response against SARS-CoV-2.
The LumiraDx D-Dimer Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify D-Dimer levels in whole blood and plasma. It is the only direct fingerstick D-Dimer assay available today*, aiding healthcare professionals to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in symptomatic patients with confidence** - in only 6 minutes.
The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in approximately < 7 minutes at the point of care.
The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP in human capillary and venous whole blood and plasma samples (Lithium Heparin). Used with the LumiraDx Platform, the LumiraDx NT-proBNP test delivers rapid, reliable results in 12 minutes at the point of care.
The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.
The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal and nasopharyngeal swab specimens from individuals suspected of COVID-19 or asymptomatic individuals. Used with the LumiraDx Platform the test delivers rapid results at the point of care.
Lab-comparable results in just 5 minutes - With excellent performance and results in just 5 minutes, the LumiraDx SARS-CoV-2 Ag Ultra test enables you to accurately and confidently test more patients, optimize clinic workflows and help triage patients without delay
